New York Life Investment Management’s Pegasystems PEGA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$363K Buy
12,096
+882
+8% +$31.6K ﹤0.01% 766
2026
Q1
$477K Buy
11,214
+3,187
+40% +$148K ﹤0.01% 756
2025
Q4
$479K Sell
8,027
-318
-4% -$18.6K ﹤0.01% 730
2025
Q3
$480K Sell
8,345
-198
-2% -$10.9K ﹤0.01% 773
2025
Q2
$462K Sell
8,543
-153
-2% -$6.93K ﹤0.01% 770
2025
Q1
$302K Buy
+8,696
New +$385K ﹤0.01% 807
2024
Q2
Sell
-10,872
Closed -$351K 1189
2024
Q1
$351K Sell
10,872
-3,376
-24% -$94.8K ﹤0.01% 1285
2023
Q4
$348K Sell
14,248
-440
-3% -$10.3K ﹤0.01% 1120
2023
Q3
$319K Sell
14,688
-2,314
-14% -$56.6K ﹤0.01% 1095
2023
Q2
$419K Sell
17,002
-3,546
-17% -$82.4K ﹤0.01% 926
2023
Q1
$498K Buy
+20,548
New +$433K 0.01% 684

Other funds holding PEGA

New York Life Investment Management's PEGA Position: Q2 2026 in Review

New York Life Investment Management increased its Pegasystems (PEGA) stake by 7.9% in Q2 2026, buying an estimated $31.6K and bringing the position to 12,096 shares worth $363K. The position accounts for ﹤0.01% of the portfolio, ranked #766.

New York Life Investment Management first reported a position in PEGA in Q1 2023 and has held it in 11 quarters since. The position peaked at $498K in Q1 2023. 278 funds tracked by Wall St. Rank hold PEGA as of Q2 2026.

  • New York Life Investment Management held 12,096 shares of Pegasystems worth $363K as of Q2 2026.
  • New York Life Investment Management bought 882 Pegasystems shares in Q2 2026, an estimated $31.6K.
  • Pegasystems made up ﹤0.01% of New York Life Investment Management's portfolio in Q2 2026, its #766 holding.
  • New York Life Investment Management first reported a position in Pegasystems in Q1 2023 and has held it in 11 quarters since.
  • New York Life Investment Management's Pegasystems position peaked at $498K in Q1 2023.
  • 278 funds tracked by Wall St. Rank held Pegasystems as of Q2 2026.

Based on New York Life Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.